MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education, and prevention. MD Anderson has ranked among the nation's top ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

Here’s what happened: December 2018: MD Anderson “self-reported a blood transfusion-related adverse event to the Food and Drug Administration (FDA),” the hospital said. The hospital did not ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

For more information, click here. From MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer ...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded ... previously untreated late-stage Hodgkin lymphoma.

Researchers at MD Anderson Cancer Center at the University of Texas ... Results from an early-stage safety trial in B-cell lymphoma have not shown any incidence of cytokine release syndrome ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be the system’s largest location yet. Services at the new facility will ...

Greenstein, Shane, Mel Martin, and Sarkis Agaian. "IBM Watson at MD Anderson Cancer Center." Harvard Business School Case 621-022, December 2020. (Revised April 2021.) ...

‘I just want to put a smile on people’s faces’ Watching how teammate Dylan Horton overcame Stage 4 Hodgkin’s lymphoma to return to play again gave Settle a perspective on cancer.

AUSTIN (KXAN) — The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital announced a joint venture dedicated to pediatric cancer care that is expected to launch in early ...